DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/shmj78/medipoint) has announced the addition of GlobalData's new report "MediPoint: Bioabsorbable Stents - US Analysis and Market Forecast" to their offering.
“MediPoint: Bioabsorbable Stents - US Analysis and Market Forecast”
The report is a vital source of up-to-date information with in-depth analysis on the Bioabsorbable Stent (BAS) Market in the US. Provided within is a comprehensive breakdown of opportunities and inhibitors within the US BAS market, highlighting testimonials from physicians from around the world utilizing this technique already. Currently, Bioabsorbable Stents have not received regulatory approval and are not available for sale in the US. The report identifies and analyzes the key trends that will drive the US Bioabsorbable Stent market in the future. The US sales expectations are discussed through careful analysis of Bioabsorbable Stent implantation procedure adoption patterns. The report provides insight into the competitive BAS landscape in the US, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by Our team of industry experts.
Key Topics Covered:
1 Tables & Figures
2 Introduction
3 Disease Overview
4 Competitive Assessment
5 Unmet Needs
6 Pipeline Products
7 Industry Overview
8 Current and Future Players
- Abbott Vascular
- Kyoto Medical Planning Co., Ltd
- Biotronik SE & Co. KG
- REVA Medical, Inc.
- Elixir Medical Corporation
- Arterial Remodeling Technologies
- Tepha, Inc.
- OrbusNeich
- Arterius
- Zorion Medical
- S3V Vascular Technologies
- ICON Interventional Systems
- Amaranth Medical
- Medlogics Device Corporation
9 Market Drivers, Opportunities and Barriers
10 Country Outlooks and Forecasts
11 Appendix
For more information visit http://www.researchandmarkets.com/research/shmj78/medipoint
Source: GlobalData





